Shalaby Wesam Shamseldin

Hallaj Shahin, Wong Jae-Chiang, Shalaby Wesam Shamseldin, Ayres Brandon D, Moster Marlene R

GATT surgery for glaucoma can rarely cause persistent, fixed mydriasis, leading to severe photosensitivity; surgical pupilloplasty may offer relief.

Shalaby Wesam Shamseldin, Patel Sonali, Lam Sophia S, Bechay Joseph, Zadrozny Izabella, Reyes Johannie et al.

This study found antithrombotic therapy did not increase transient hyphema risk after trabecular bypass microstent surgery. Hyphema was linked to stent type and female sex, offering guidance for surgical planning.

Shalaby Wesam Shamseldin, Ahmed Osama M, Waisbourd Michael, Katz L Jay

This review explores non-IOP-dependent glaucoma therapies, finding many promising neuroprotective/neuroregenerative strategies are being investigated to prevent vision loss where IOP reduction fails.

Shalaby Wesam Shamseldin, Bechay Joseph, Myers Jonathan S, Lee Daniel, Razeghinejad Reza, Kolomeyer Natasha Nayak et al.

This study found a low 5.3% reoperation rate within 90 days of MIGS, mainly for elevated IOP or gel microstent issues, suggesting MIGS is generally safe short-term but highlights specific complication risks.

Shalaby Wesam Shamseldin, Jia Jing, Katz L Jay, Lee Daniel

This review of iStent inject found this microinvasive glaucoma device is safe and effective for open-angle glaucoma, offering IOP reduction with minimal trauma.